Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03207893 · ClinicalTrials.gov registry record · NA

Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03207893 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03207893, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to determine if the use of continuous glucose monitoring with the GEM lifestyle modification program (Glycemic load, Exercise and Monitoring glucose) will result in better diabetes control than routine care.

Interventions

  • OTHER Routine Care
  • BEHAVIORAL GEM lifestyle modification & continuous glucose monitoring

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-07-19
Est. Completion 2020-01-23
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT03207893

The ClinicalTrials.gov registry entry for NCT03207893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Routine Care is the first listed.

NCT03207893 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03207893 about?

NCT03207893 is a clinical study titled "Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes". The purpose of this study is to determine if the use of continuous glucose monitoring with the GEM lifestyle modification program (Glycemic load, Exercise and Monitoring glucose) will result in better diabetes control than routine care.

What is the current status of trial NCT03207893?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-07-19. Estimated completion is 2020-01-23.

What interventions are being tested in trial NCT03207893?

The interventions under investigation include: Routine Care (OTHER), GEM lifestyle modification & continuous glucose monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT03207893?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.